P144 cream
( DrugBank: - / KEGG DRUG: - )
1 disease
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
51 | Scleroderma | 10 |
51. Scleroderma
Clinical trials : 525 / Drugs : 565 - (DrugBank : 148) / Drug target genes : 114 - Drug target pathways : 217
Showing 1 to 10 of 10 trials
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | EUCTR2008-001265-28-IT (EUCTR) | 02/03/201020100302 | 07/12/200920091207 | Open Label Extension (OLE) for the patients treated in the ISD002-P144-07 study with P144 topical administration for skin fibrosis in patients with systemic sclerosis - ND Open Label Extension (OLE) for the patients treated in the ISD002-P144-07 study with P144 topical ad ... | Open Label Extension (OLE) for the patients treated in the ISD002-P144-07 study with P144 topical administration for skin fibrosis in patients with systemic sclerosis - ND Open Label Extension (OLE) for the patients treated in the ISD002-P144-07 study with P144 topical ad ... | skin fibrosis of systemic sclerosis patients MedDRA version: 12.1;Level: LLT;Classification code 10039710;Term: Scleroderma skin fibrosis of systemic sclerosis patients MedDRA version: 12.1;Level: LLT;Classification code 100 ... | Product Name: P144. Cytokines Inhibitors Product Code: P144 INN or Proposed INN: P144 Cytokines Inhibitors Product Name: P144. Cytokines Inhibitors Product Code: P144 INN or Proposed INN: P144 Cytokines Inhibi ... | ISDIN S.A. | NULL | Not Recruiting | Female: yes Male: yes | 98 | Hungary;United Kingdom;Germany;Spain;Italy | |||
2 | EUCTR2008-001265-28-GB (EUCTR) | 14/11/200820081114 | 19/08/200820080819 | Open Label Extension (OLE) for the patients treated in the ISD002-P144-07 study with P144 topical administration for skin fibrosis in patients with systemic sclerosis - OLE Open Label Extension (OLE) for the patients treated in the ISD002-P144-07 study with P144 topical ad ... | Open Label Extension (OLE) for the patients treated in the ISD002-P144-07 study with P144 topical administration for skin fibrosis in patients with systemic sclerosis - OLE Open Label Extension (OLE) for the patients treated in the ISD002-P144-07 study with P144 topical ad ... | Skin fibrosis in patients with systemic sclerosis MedDRA version: 9.1;Level: LLT;Classification code 10039710;Term: Scleroderma Skin fibrosis in patients with systemic sclerosis MedDRA version: 9.1;Level: LLT;Classification code ... | Product Name: P144 Product Code: P144. Cytokines Inhibitors INN or Proposed INN: P144 Other descriptive name: DIGNA P144 cream Product Name: P144 Product Code: P144. Cytokines Inhibitors INN or Proposed INN: P144 Other descriptive ... | ISDIN | NULL | Not Recruiting | Female: yes Male: yes | 98 | Hungary;Germany;United Kingdom;Spain;Italy | |||
3 | EUCTR2008-001265-28-DE (EUCTR) | 13/10/200820081013 | 19/05/200820080519 | OFFENE (UNVERBLINDETE) VERLÄNGERUNGSTUDIE FÜR PATIENTEN AUS DER ISD002-P144-07 STUDIE MIT TOPISCH AUFGETRAGENEM P144 AUF HAUTFIBROSEN BEI PATIENTEN MIT SYSTEMISCHER SKLEROSEOpen Label Extension (OLE) for the patients treated in the ISD002-P144-07 study with P144 topical administration for skin fibrosis in patients with systemic sclerosis” - OLE OFFENE (UNVERBLINDETE) VERLÄNGERUNGSTUDIE FÜR PATIENTEN AUS DER ISD002-P144-07 STUDIE MIT TOPISCH AU ... | OFFENE (UNVERBLINDETE) VERLÄNGERUNGSTUDIE FÜR PATIENTEN AUS DER ISD002-P144-07 STUDIE MIT TOPISCH AUFGETRAGENEM P144 AUF HAUTFIBROSEN BEI PATIENTEN MIT SYSTEMISCHER SKLEROSEOpen Label Extension (OLE) for the patients treated in the ISD002-P144-07 study with P144 topical administration for skin fibrosis in patients with systemic sclerosis” - OLE OFFENE (UNVERBLINDETE) VERLÄNGERUNGSTUDIE FÜR PATIENTEN AUS DER ISD002-P144-07 STUDIE MIT TOPISCH AU ... | Skin fibrosis in patients with systemic sclerosis MedDRA version: 9.1;Level: LLT;Classification code 10039710;Term: Scleroderma Skin fibrosis in patients with systemic sclerosis MedDRA version: 9.1;Level: LLT;Classification code ... | Product Name: P144 Product Code: P144 Cytokine Inhibitor INN or Proposed INN: P144 Other descriptive name: DIGNA P144 cream Product Name: P144 Product Code: P144 Cytokine Inhibitor INN or Proposed INN: P144 Other descriptive na ... | ISDIN | NULL | Not Recruiting | Female: yes Male: yes | 98 | Hungary;Spain;Germany;Italy;United Kingdom | |||
4 | EUCTR2008-001265-28-HU (EUCTR) | 18/09/200820080918 | 05/08/200820080805 | Open Label Extension (OLE) for the patients treated in the ISD002-P144-07 study with P144 topical administration for skin fibrosis in patients with systemic sclerosis.Az ISD002-P144-07 vizsgálat nyílt kiterjesztése P144-gyel kezelt, szisztémás szklerózisban szenvedo betegek felületi borfibrózisának kezelésében. - OLE Open Label Extension (OLE) for the patients treated in the ISD002-P144-07 study with P144 topical ad ... | Open Label Extension (OLE) for the patients treated in the ISD002-P144-07 study with P144 topical administration for skin fibrosis in patients with systemic sclerosis.Az ISD002-P144-07 vizsgálat nyílt kiterjesztése P144-gyel kezelt, szisztémás szklerózisban szenvedo betegek felületi borfibrózisának kezelésében. - OLE Open Label Extension (OLE) for the patients treated in the ISD002-P144-07 study with P144 topical ad ... | Skin fibrosis in patients with systemic sclerosis.Szisztémás szklerózisban szenvedo betegek. MedDRA version: 9.1;Level: LLT;Classification code 10039710;Term: Scleroderma Skin fibrosis in patients with systemic sclerosis.Szisztémás szklerózisban szenvedo betegek. MedDRA ... | Product Name: P144 Product Code: P144 Cytokines Inhibitors INN or Proposed INN: P144 Other descriptive name: DIGNA P144 cream Product Name: P144 Product Code: P144 Cytokines Inhibitors INN or Proposed INN: P144 Other descriptive ... | ISDIN | NULL | Not Recruiting | Female: yes Male: yes | 98 | Hungary;United Kingdom;Germany;Spain;Italy | |||
5 | NCT00781053 (ClinicalTrials.gov) | July 200820080700 | 24/10/200820081024 | Open Label Extension (OLE) for the Patients Treated in the ISD002-P144-07 Study | Open Label Extension (OLE) for the Patients Treated in the ISD002-P144-07 Study With P144 Topical Adminsitration for Skin Fibrosis in Patients With Systemic Sclerosis Open Label Extension (OLE) for the Patients Treated in the ISD002-P144-07 Study With P144 Topical Ad ... | Skin Fibrosis | Drug: P144 cream | ISDIN | Digna Biotech S.L. | Completed | 18 Years | 65 Years | Both | 38 | Phase 2 | Germany;Hungary;Italy;Poland;Spain;United Kingdom |
6 | EUCTR2008-001265-28-ES (EUCTR) | 17/06/200820080617 | 08/04/200820080408 | Estudio abierto de extensión con P144 para la ampliación del tratamiento tópico de la fibrosis cutánea de pacientes con esclerosis sistémica previamente tratados en el ensayo ISD002-P144-07 Open Label Extension (OLE) for the patients treated in the ISD002-P144-07 study with P144 topical administration for skin fibrosis in patients with systemic sclerosis” - OLE Estudio abierto de extensión con P144 para la ampliación del tratamiento tópico de la fibrosis cután ... | Estudio abierto de extensión con P144 para la ampliación del tratamiento tópico de la fibrosis cutánea de pacientes con esclerosis sistémica previamente tratados en el ensayo ISD002-P144-07 Open Label Extension (OLE) for the patients treated in the ISD002-P144-07 study with P144 topical administration for skin fibrosis in patients with systemic sclerosis” - OLE Estudio abierto de extensión con P144 para la ampliación del tratamiento tópico de la fibrosis cután ... | Fibrosis cutánea de pacientes con esclerosis sistémicaSkin fibrosis in patients with systemic sclerosis MedDRA version: 9.1;Level: LLT;Classification code 10039710;Term: Scleroderma Fibrosis cutánea de pacientes con esclerosis sistémicaSkin fibrosis in patients with systemic sclero ... | Product Name: P144 Product Code: P144. Cytokines Inhibitors INN or Proposed INN: P144 Other descriptive name: DIGNA P144 cream Product Name: P144 Product Code: P144. Cytokines Inhibitors INN or Proposed INN: P144 Other descriptive ... | ISDIN | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | 98 | Hungary;United Kingdom;Germany;Spain;Italy | |||
7 | EUCTR2007-002015-38-DE (EUCTR) | 20/12/200720071220 | 03/08/200720070803 | PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, INTRAINDIVIDUALLY PLACEBO CONTROLLED CLINICAL TRIAL, TO EVALUATE EFFICACY AND SAFETY OF P144 TOPICAL ADMINISTRATION FOR SKIN FIBROSIS IN PATIENTS WITH SYSTEMIC SCLEROSIS. PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, INTRAINDIVIDUALLY PLACEBO CONTROLLED CLINICAL TRIAL ... | PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, INTRAINDIVIDUALLY PLACEBO CONTROLLED CLINICAL TRIAL, TO EVALUATE EFFICACY AND SAFETY OF P144 TOPICAL ADMINISTRATION FOR SKIN FIBROSIS IN PATIENTS WITH SYSTEMIC SCLEROSIS. PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, INTRAINDIVIDUALLY PLACEBO CONTROLLED CLINICAL TRIAL ... | SKIN FIBROSIS IN PATIENTS WITH SYSTEMIC SCLEROSIS MedDRA version: 9.1;Level: LLT;Classification code 10039710;Term: Scleroderma SKIN FIBROSIS IN PATIENTS WITH SYSTEMIC SCLEROSIS MedDRA version: 9.1;Level: LLT;Classification code ... | Product Name: P144 Product Code: P144 Other descriptive name: DIGNA P144 CREAM | ISDIN | NULL | Not Recruiting | Female: yes Male: yes | 98 | Phase 2 | Hungary;Spain;Germany;Italy;United Kingdom | ||
8 | EUCTR2007-002015-38-GB (EUCTR) | 19/12/200720071219 | 31/07/200720070731 | PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, INTRAINDIVIDUALLY PLACEBO CONTROLLED CLINICAL TRIAL, TO EVALUATE EFFICACY AND SAFETY OF P144 TOPICAL ADMINISTRATION FOR SKIN FIBROSIS IN PATIENTS WITH SYSTEMIC SCLEROSIS. PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, INTRAINDIVIDUALLY PLACEBO CONTROLLED CLINICAL TRIAL ... | PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, INTRAINDIVIDUALLY PLACEBO CONTROLLED CLINICAL TRIAL, TO EVALUATE EFFICACY AND SAFETY OF P144 TOPICAL ADMINISTRATION FOR SKIN FIBROSIS IN PATIENTS WITH SYSTEMIC SCLEROSIS. PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, INTRAINDIVIDUALLY PLACEBO CONTROLLED CLINICAL TRIAL ... | SKIN FIBROSIS IN PATIENTS WITH SYSTEMIC SCLEROSIS MedDRA version: 9.1;Level: LLT;Classification code 10039710;Term: Scleroderma SKIN FIBROSIS IN PATIENTS WITH SYSTEMIC SCLEROSIS MedDRA version: 9.1;Level: LLT;Classification code ... | Product Name: P144 DIGNA CREAM Product Code: P144 Other descriptive name: DIGNA P144 CREAM | ISDIN | NULL | Not Recruiting | Female: yes Male: yes | 98 | Phase 2 | Hungary;Spain;Germany;Italy;United Kingdom | ||
9 | EUCTR2007-002015-38-HU (EUCTR) | 04/09/200720070904 | 09/07/200720070709 | Phase II, multicenter, randomized, double-blind, intraindividually placebo controlled clinical trial, to evaluate efficacy and safety of P144 topical administration for skin fibrosis in patients with systemic sclerosis.Fázis II, multicentrikus, randomizált, kettos vak, egyénenként placebóval kontrollált klinikai vizsgálat, különbözo koncentrációjú topikus P144 hatékonyságának és biztonságosságának megállapítása szisztémás sclerosis-ban szenvedo páciensek bor fibrózisának kezelésében. Phase II, multicenter, randomized, double-blind, intraindividually placebo controlled clinical trial ... | Phase II, multicenter, randomized, double-blind, intraindividually placebo controlled clinical trial, to evaluate efficacy and safety of P144 topical administration for skin fibrosis in patients with systemic sclerosis.Fázis II, multicentrikus, randomizált, kettos vak, egyénenként placebóval kontrollált klinikai vizsgálat, különbözo koncentrációjú topikus P144 hatékonyságának és biztonságosságának megállapítása szisztémás sclerosis-ban szenvedo páciensek bor fibrózisának kezelésében. Phase II, multicenter, randomized, double-blind, intraindividually placebo controlled clinical trial ... | SKIN FIBROSIS IN PATIENTS WITH SYSTEMIC SCLEROSIS MedDRA version: 9.1;Level: LLT;Classification code 10039710;Term: Scleroderma SKIN FIBROSIS IN PATIENTS WITH SYSTEMIC SCLEROSIS MedDRA version: 9.1;Level: LLT;Classification code ... | Product Name: P144 Product Code: P144 Other descriptive name: DIGNA P144 CREAM | ISDIN | NULL | Not Recruiting | Female: yes Male: yes | 98 | Phase 2 | Hungary;Germany;United Kingdom;Spain;Italy | ||
10 | EUCTR2007-002015-38-ES (EUCTR) | 23/08/200720070823 | 02/07/200720070702 | ENSAYO CLÍNICO MULTICÉNTRICO, FASE II, ALEATORIZADO, DOBLE CIEGO, CONTROLADO INTRAINDIVIDUALMENTE CON PLACEBO, PARA EVALUAR LA EFICACIA Y SEGURIDAD DE P144 EN EL TRATAMIENTO TÓPICO DE LA FIBROSIS CUTÁNEA DE PACIENTES CON ESCLEROSIS SISTÉMICAPHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, INTRAINDIVIDUALLY PLACEBO CONTROLLED CLINICAL TRIAL, TO EVALUATE EFFICACY AND SAFETY OF P144 TOPICAL ADMINISTRATION FOR SKIN FIBROSIS IN PATIENTS WITH SYSTEMIC SCLEROSIS ENSAYO CLÍNICO MULTICÉNTRICO, FASE II, ALEATORIZADO, DOBLE CIEGO, CONTROLADO INTRAINDIVIDUALMENTE CO ... | ENSAYO CLÍNICO MULTICÉNTRICO, FASE II, ALEATORIZADO, DOBLE CIEGO, CONTROLADO INTRAINDIVIDUALMENTE CON PLACEBO, PARA EVALUAR LA EFICACIA Y SEGURIDAD DE P144 EN EL TRATAMIENTO TÓPICO DE LA FIBROSIS CUTÁNEA DE PACIENTES CON ESCLEROSIS SISTÉMICAPHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, INTRAINDIVIDUALLY PLACEBO CONTROLLED CLINICAL TRIAL, TO EVALUATE EFFICACY AND SAFETY OF P144 TOPICAL ADMINISTRATION FOR SKIN FIBROSIS IN PATIENTS WITH SYSTEMIC SCLEROSIS ENSAYO CLÍNICO MULTICÉNTRICO, FASE II, ALEATORIZADO, DOBLE CIEGO, CONTROLADO INTRAINDIVIDUALMENTE CO ... | FIBROSIS CUTÁNEA DE PACIENTES CON ESCLEROSIS SISTÉMICASKIN FIBROSIS IN PATIENTS WITH SYSTEMIC SCLEROSIS MedDRA version: 9.1;Level: LLT;Classification code 10039710;Term: Scleroderma FIBROSIS CUTÁNEA DE PACIENTES CON ESCLEROSIS SISTÉMICASKIN FIBROSIS IN PATIENTS WITH SYSTEMIC SCLERO ... | Product Name: P144 Product Code: P144 Other descriptive name: DIGNA P144 CREAM | ISDIN | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | 98 | Phase 2 | Hungary;Germany;United Kingdom;Spain;Italy |